AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H1443-H1451, 2007. First published November 10, 2006; doi:10.1152/ajpheart.01056.2006
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/H1443    most recent
01056.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sekiguchi, K.
Right arrow Articles by Barger, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sekiguchi, K.
Right arrow Articles by Barger, P. M.

Inhibition of PPAR-{alpha} activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3

Kenichi Sekiguchi, Qi Tian, Masakuni Ishiyama, Jana Burchfield, Feng Gao, Douglas L. Mann, and Philip M. Barger

Winters Center for Heart Failure Research, Department of Medicine, Baylor College of Medicine, Houston, Texas

Submitted 26 September 2006 ; accepted in final form 6 November 2006

A shift in energy substrate utilization from fatty acids to glucose has been reported in failing hearts, resulting in improved oxygen efficiency yet perhaps also contributing to a state of energy deficiency. Peroxisome proliferator-activated receptor (PPAR)-{alpha}, the principal transcriptional regulator of cardiac fatty acid beta-oxidation (FAO) genes, is downregulated in heart failure, and this may contribute to reduced fatty acid utilization. Cardiomyopathic states are also accompanied by elevated levels of circulating cytokines, such as tumor necrosis factor (TNF), as well as increased local production of cytokines and profibrotic factors, such as transforming growth factor (TGF)-beta. However, whether these molecular pathways directly modulate cardiac energy metabolism and PPAR-{alpha} activity is not known. Therefore, FAO capacity and FAO gene expression were determined in mice with cardiac-restricted overexpression of TNF (MHCsTNF3). MHCsTNF3 hearts had significantly lower FAO capacity and decreased expression of PPAR-{alpha} and FAO target genes compared with control hearts. Surprisingly, TNF had little effect on PPAR-{alpha} activity and FAO rates in cultured ventricular myocytes, suggesting that TNF acts indirectly on myocyte FAO in vivo. We found that TGF-beta expression was upregulated in MHCsTNF3 hearts and that treatment of cultured myocytes with TGF-beta significantly suppressed FAO rates and directly impaired PPAR-{alpha} activity, a result reproduced by Smad3 overexpression. This work demonstrates that TGF-beta signaling pathways directly suppress PPAR-{alpha} activity and reduce FAO in cardiac myocytes, perhaps in response to locally elevated TNF. Although speculative, TGF-beta-driven repair mechanisms may also include the additional benefit of limiting FAO in injured myocardium.

metabolism; inflammation; genes; signal transduction



Address for reprint requests and other correspondence: P. M. Barger, Winters Center for Heart Failure Research, Baylor College of Medicine, 6621 Fannin St., FC0450.01, Houston, TX 77030 (e-mail: pbarger{at}bcm.edu)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Pellieux, C. Montessuit, I. Papageorgiou, and R. Lerch
Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-{alpha}
Cardiovasc Res, May 1, 2009; 82(2): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. K. LeBrasseur, T.-A. S. Duhaney, D. S. De Silva, L. Cui, P. C. Ip, L. Joseph, and F. Sam
Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension
Hypertension, September 1, 2007; 50(3): 489 - 496.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. H. Remels, P. Schrauwen, R. Broekhuizen, J. Willems, S. Kersten, H. R. Gosker, and A. M. Schols
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
Eur. Respir. J., August 1, 2007; 30(2): 245 - 252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.